Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Bausch & Lomb

This article was originally published in The Tan Sheet

Executive Summary

Bausch & Lomb: Senior VP and Global Business Manager for Lens Care Products James Kanaley named senior VP and president-North American vision care. Carl Sassano, currently senior VP and global business manager for contact lenses is named senior VP and global business manager-vision care. The appointments are made in accord with a "global vision care strategy," announced in April, intended to create a single U.S. vision care product business and "leverage the competitive advantages inherent in the company's soft and rigid gas permeable contact lens, lens care, general and prescription eye care businesses on a worldwide basis," the firm says...

Bausch & Lomb: Senior VP and Global Business Manager for Lens Care Products James Kanaley named senior VP and president-North American vision care. Carl Sassano, currently senior VP and global business manager for contact lenses is named senior VP and global business manager-vision care. The appointments are made in accord with a "global vision care strategy," announced in April, intended to create a single U.S. vision care product business and "leverage the competitive advantages inherent in the company's soft and rigid gas permeable contact lens, lens care, general and prescription eye care businesses on a worldwide basis," the firm says....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085528

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel